Last updated: 11/03/2018 12:05:58
Quality of Life(QoL) in Korean postmenopausal osteoporosis patients with bisphosphonate treatmentBRAVO
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Finalized
Finalized
Trial overview
Official title: Quality of Life(QoL) in Korean postmenopausal osteoporosis patients with bisphosphonate treatment
Trial description: Quality of Life (QoL) in Korean postmenopausal osteoporosis patients with bisphosphonate treatment
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Mean of composite satisfaction score (CSS) of OPSAT-QTM
Timeframe: 0day
Secondary outcomes:
Mean of subscale satisfaction scores of OPSAT-QTM
Timeframe: oday
Interventions:
Other: OPSAT-Q
Enrollment:
4376
Observational study model:
Other
Primary completion date:
Not applicable
Time perspective:
Cross-Sectional
Clinical publications:
Not applicable
Medical condition
Osteoporosis, Postmenopausal
Product
Not applicable
Collaborators
Not applicable
Study date(s)
June 2008 to November 2008
Type
Observational
Phase
Not applicable
Participation criteria
Sex
Female
Age
18+ years
Accepts healthy volunteers
No
- Who have been diagnosed with postmenopausal osteoporosis by physician
- Who have received any oral bisphosphonates (weekly or monthly) at least for 2 months to provide answer of OPSAT-QTM questionnaire
- Do not understand the contents of the questionnaire
Inclusion and exclusion criteria
Inclusion criteria:
- Who have been diagnosed with postmenopausal osteoporosis by physician Who have received any oral bisphosphonates (weekly or monthly) at least for 2 months to provide answer of OPSAT-QTM questionnaire Who provide informed consent for study participation
Exclusion criteria:
- Do not understand the contents of the questionnaire
Trial location(s)
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Finalized
Actual primary completion date
Not applicable
Actual study completion date
2008-20-11
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website